Homchampa P, Strugnell R A, Adler B
Department of Microbiology, Monash University, Clayton, Australia.
Vaccine. 1997 Feb;15(2):203-8. doi: 10.1016/s0264-410x(96)00139-9.
The aroA gene from Pasteurella multocida serotype A:1 (X-73) was cloned by complementation of the Escherichia coli aroA mutant AB2829 with a DNA library constructed in pUC18. The cloned aroA gene was inactivated by deletion of a 300 bp internal sequence and reintroduced by homologous recombination into the chromosome of X-73 and P-1059 (serotype A:3) using a Pasteurella-E. coli shuttle vector pPBA1100. By subjecting the transformed cells to repeated subculturing in the presence of antibiotic selection coupled with auxotrophic enrichment, marker-free aroA mutants of X-73 and of P-1059 were isolated and designated PMP1 and PMP3, respectively. PMP1 and PMP3 were highly attenuated and capable of conferring complete protection against subsequent lethal challenge infection in a mouse model. Moreover, PMP3-immunized mice were protected against heterologous challenge infection with serotype A:1 or A:4.
用构建于pUC18的DNA文库对大肠杆菌aroA突变体AB2829进行互补,从而克隆出多杀性巴氏杆菌A:1血清型(X-73)的aroA基因。通过缺失300 bp内部序列使克隆的aroA基因失活,然后使用巴氏杆菌-大肠杆菌穿梭载体pPBA1100通过同源重组将其重新导入X-73和P-1059(A:3血清型)的染色体中。通过在抗生素选择存在下对转化细胞进行反复传代培养并结合营养缺陷型富集,分离出X-73和P-1059的无标记aroA突变体,分别命名为PMP1和PMP3。PMP1和PMP3高度减毒,能够在小鼠模型中对随后的致死性攻击感染提供完全保护。此外,用PMP3免疫的小鼠能够抵抗A:1或A:4血清型的异源攻击感染。